[Polymyxin B treatment of endotoxinemia in liver cirrhosis].
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004731:Endotoxins / Q000037:antagonists & inhibitors / Q000097:blood*; D005632:Fructose / Q000627:therapeutic use; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications* / Q000188:drug therapy; D008111:Liver Function Tests; D009355:Neomycin / Q000627:therapeutic use; D011112:Polymyxin B / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D014115:Toxemia / Q000188:drug therapy* / Q000209:etiology
D004731:Endotoxins; D011113:Polymyxins; D005632:Fructose; D009355:Neomycin; D011112:Polymyxin B
Die Behandlung der Endotoxinämie bei Leberzirrhose mit Polymyxin B.